Targeted Therapy for the Loss of Von Hippel-Lindau in Renal Cell Carcinoma: A Novel Molecule That Induces Autophagic Cell Death

Autophagy - United States
doi 10.4161/auto.6785
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

4-Pyridylanilinothiazoles That Selectively Target Von Hippel−Lindau Deficient Renal Cell Carcinoma Cells by Inducing Autophagic Cell Death

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma

Journal of Kidney Cancer and VHL
2015English

Quantitative Proteomics to Study a Small Molecule Targeting the Loss of Von Hippel-Lindau in Renal Cell Carcinomas

International Journal of Cancer
Cancer ResearchOncology
2017English

Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

-Catenin Links Von Hippel-Lindau to Aurora Kinase a and Loss of Primary Cilia in Renal Cell Carcinoma

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Mp19-04 Ct-Based Volumetric Characterization of Renal Clear Cell Carcinoma in Von Hippel-Lindau (Vhl) Using Novel Histogram Analysis.

Journal of Urology
Urology
2016English

Hypoxia Upregulates Von Hippel-Lindau Tumor-Suppressor Protein Through RhoA-dependent Activity in Renal Cell Carcinoma

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2004English

Targeted Therapy for Renal Cell Carcinoma

2011English

Von Hippel-Lindau

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy